黑介导的代谢变化在与直肠多回归相关的家族腺瘤多症患者
Yi-Wen Huang1, Hui-Zhi Chen2, Ben Niu2
1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
概括
黑色树 (BRB) 在治疗家族性腺瘤多重症 (FAP) 中表现有前途. 这项研究发现,BRB干预在FAP患者中显著改变了代谢物,可能有助于直肠息肉回归.
科学领域:
- 生物化学 生化学
- 在瘤学瘤学.
- 营养科学 营养科学
背景情况:
- 家族性腺瘤多重症 (FAP) 具有近100%的结直肠癌风险,通常需要预防性切除.
- 在FAP患者中阻碍结直肠癌的进展是一个关键的临床目标.
- 黑色树 (BRB) 已显示出在FAP患者中减少直肠多的潜力.
研究的目的:
- 为了研究黑 (BRB) 干预引起的代谢变化,在家族腺瘤多重症 (FAP) 患者中.
- 在FAP响应者中识别BRB调节的特定代谢途径.
- 探索BRBs在FAP管理中的潜在治疗机制.
主要方法:
- 使用基于质谱的非向代谢学.
- 分析了接受BRB治疗的FAP患者的干预前后尿液和血样本.
- 专注于11名患者,他们在BRB干预9个月后显示了直肠多的减少.
主要成果:
- 在BRB反应者中确定了23种尿和6种血代谢物的显著变化.
- 观察到关键代谢途径的变化,包括聚胺,谷氨,三碳酸循环,内醇和酸代谢.
- 在干预后检测到来自BRB多的代谢物水平增加.
结论:
- 黑 (BRB) 干预显著调节FAP患者的多种代谢途径.
- 由BRB诱导的代谢变化,包括高聚衍生代谢物,表明FAP中直肠多回归的机制.
- BRBs对于管理家族腺瘤多重症和预防结直肠癌进展具有潜在的治疗价值.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
874
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
144
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
144
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
